Cargando…

DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection

BACKGROUND: Nanoparticles (NPs) are viable candidates as carriers of exogenous materials into cells via transfection and can be used in the DNA vaccination strategy against leptospirosis. OBJECTIVES: We evaluated the efficiency of halloysite clay nanotubes (HNTs) and amine-functionalised multi-walle...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Thaís Larré, Bacelo, Kátia Leston, Forster, Karine Maciel, Ilha, Vinicius, Rodrigues, Oscar Endrigo, Hartwig, Daiane D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164400/
https://www.ncbi.nlm.nih.gov/pubmed/32321154
http://dx.doi.org/10.1590/0074-02760190396
_version_ 1783523286355804160
author Oliveira, Thaís Larré
Bacelo, Kátia Leston
Forster, Karine Maciel
Ilha, Vinicius
Rodrigues, Oscar Endrigo
Hartwig, Daiane D
author_facet Oliveira, Thaís Larré
Bacelo, Kátia Leston
Forster, Karine Maciel
Ilha, Vinicius
Rodrigues, Oscar Endrigo
Hartwig, Daiane D
author_sort Oliveira, Thaís Larré
collection PubMed
description BACKGROUND: Nanoparticles (NPs) are viable candidates as carriers of exogenous materials into cells via transfection and can be used in the DNA vaccination strategy against leptospirosis. OBJECTIVES: We evaluated the efficiency of halloysite clay nanotubes (HNTs) and amine-functionalised multi-walled carbon nanotubes (NH(2)-MWCNTs) in facilitating recombinant LemA antigen (rLemA) expression and protecting Golden Syrian hamsters (Mesocricetus auratus) against Leptospira interrogans lethal infection. METHODS: An indirect immunofluorescent technique was used to investigate the potency of HNTs and NH(2)-MWCNTs in enhancing the transfection and expression efficiency of the DNA vaccine in Chinese hamster ovary (CHO) cells. Hamsters were immunised with two doses of vaccines HNT-pTARGET/lemA, NH(2)-MWCNTs-pTARGET/lemA, pTARGET/lemA, and empty pTARGET (control), and the efficacy was determined in terms of humoral immune response and protection against a lethal challenge. FINDINGS: rLemA DNA vaccines carried by NPs were able to transfect CHO cells effectively, inducing IgG immune response in hamsters (p < 0.05), and did not exhibit cytotoxic effects. Furthermore, 83.3% of the hamsters immunised with NH(2)-MWCNTs-pTARGET/lemA were protected against the lethal challenge (p < 0.01), and 66.7% of hamsters immunised with HNT-pTARGET/lemA survived (p < 0.05). MAIN CONCLUSIONS: NH(2)-MWCNTs and HNTs can act as antigen carriers for mammalian cells and are suitable for DNA nanovaccine delivery.
format Online
Article
Text
id pubmed-7164400
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Instituto Oswaldo Cruz, Ministério da Saúde
record_format MEDLINE/PubMed
spelling pubmed-71644002020-04-23 DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection Oliveira, Thaís Larré Bacelo, Kátia Leston Forster, Karine Maciel Ilha, Vinicius Rodrigues, Oscar Endrigo Hartwig, Daiane D Mem Inst Oswaldo Cruz Original Article BACKGROUND: Nanoparticles (NPs) are viable candidates as carriers of exogenous materials into cells via transfection and can be used in the DNA vaccination strategy against leptospirosis. OBJECTIVES: We evaluated the efficiency of halloysite clay nanotubes (HNTs) and amine-functionalised multi-walled carbon nanotubes (NH(2)-MWCNTs) in facilitating recombinant LemA antigen (rLemA) expression and protecting Golden Syrian hamsters (Mesocricetus auratus) against Leptospira interrogans lethal infection. METHODS: An indirect immunofluorescent technique was used to investigate the potency of HNTs and NH(2)-MWCNTs in enhancing the transfection and expression efficiency of the DNA vaccine in Chinese hamster ovary (CHO) cells. Hamsters were immunised with two doses of vaccines HNT-pTARGET/lemA, NH(2)-MWCNTs-pTARGET/lemA, pTARGET/lemA, and empty pTARGET (control), and the efficacy was determined in terms of humoral immune response and protection against a lethal challenge. FINDINGS: rLemA DNA vaccines carried by NPs were able to transfect CHO cells effectively, inducing IgG immune response in hamsters (p < 0.05), and did not exhibit cytotoxic effects. Furthermore, 83.3% of the hamsters immunised with NH(2)-MWCNTs-pTARGET/lemA were protected against the lethal challenge (p < 0.01), and 66.7% of hamsters immunised with HNT-pTARGET/lemA survived (p < 0.05). MAIN CONCLUSIONS: NH(2)-MWCNTs and HNTs can act as antigen carriers for mammalian cells and are suitable for DNA nanovaccine delivery. Instituto Oswaldo Cruz, Ministério da Saúde 2020-04-17 /pmc/articles/PMC7164400/ /pubmed/32321154 http://dx.doi.org/10.1590/0074-02760190396 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
Oliveira, Thaís Larré
Bacelo, Kátia Leston
Forster, Karine Maciel
Ilha, Vinicius
Rodrigues, Oscar Endrigo
Hartwig, Daiane D
DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection
title DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection
title_full DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection
title_fullStr DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection
title_full_unstemmed DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection
title_short DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection
title_sort dna nanovaccines prepared using lema antigen protect golden syrian hamsters against leptospira lethal infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164400/
https://www.ncbi.nlm.nih.gov/pubmed/32321154
http://dx.doi.org/10.1590/0074-02760190396
work_keys_str_mv AT oliveirathaislarre dnananovaccinespreparedusinglemaantigenprotectgoldensyrianhamstersagainstleptospiralethalinfection
AT bacelokatialeston dnananovaccinespreparedusinglemaantigenprotectgoldensyrianhamstersagainstleptospiralethalinfection
AT forsterkarinemaciel dnananovaccinespreparedusinglemaantigenprotectgoldensyrianhamstersagainstleptospiralethalinfection
AT ilhavinicius dnananovaccinespreparedusinglemaantigenprotectgoldensyrianhamstersagainstleptospiralethalinfection
AT rodriguesoscarendrigo dnananovaccinespreparedusinglemaantigenprotectgoldensyrianhamstersagainstleptospiralethalinfection
AT hartwigdaianed dnananovaccinespreparedusinglemaantigenprotectgoldensyrianhamstersagainstleptospiralethalinfection